Introduction: The presence of multiple renal arteries (MRA) in the donor allograft was once a contraindication to transplantation. Despite concerns about risks, these allografts are being increasingly used to overcome a shortage of renal donors. Objectives: To compare the outcomes of live-donor renal allografts with multiple and single renal arteries (SRA) in terms of overall ischemia times, early and late graft function, and vascular and urological complications. Methods: A prospective, non-randomized cohort study was conducted including all live donor renal transplants done by the Vascular and Transplant
Introduction
The presence of multiple renal arteries (MRA) in prospective renal donors was once considered a relative contraindication to live donor renal transplantation (LDRT). This presumed technical difficulty in anastomosis and potential for increased vascular and secondary urological complications resulted in many potential healthy donors being overlooked for more favourable renal anatomy in deceased donors or alternate live donors [1] . However, the increasing disparity between the escalating demand for renal transplantation and relatively stagnant supply of deceased donor organs has made it prohibitive for potential live donors to be declined based on arterial anatomy [2] [3] . Despite the technical difficulties and potential complications of transplanting donor kidneys with MRA, these organs are increasingly accepted to maximize the pool of acceptable donors [4] . With increasing expertise in vascular reconstruction and surgical tech- 
Methods
We conducted a prospective cohort study of all LDRT performed between March Patients were divided into three groups: Group 1; single artery single anastomosis, Group 2; multiple arteries with single conjoined anastomosis, and Group 3: multiple arteries with two or more anastomoses. Whenever MRA were present, they were preferentially reconstructed on the "back-table" with side to side vertical spatulation to form a single opening using 7/0 polypropylene suture. All back-table reconstructions were carried out by the same specialist surgeon and although not included in the statistical analysis, the anastomotic time was kept below 10 minutes. Where the individual arteries were placed wide apart in the hilum not allowing a tension-free reconstruction, they were left for individual separate "on-table" anastomosis. Smaller capsular arteries that perfused less than 5% of the graft during back-table perfusion were ligated and not considered for reconstruction. In groups 1 and 2, the donor arteries were anastomosed to the recipient External Iliac Artery (EIA) in an end-to-side fashion using a continuous 6/0 polypropylene suture. In group 3, the anastomoses were done with the larger donor artery to the recipient EIA and the smaller donor artery to the recipient Inferior Epigastric Artery (IEA). The donor artery to IEA anastomosis was done in an end-to-end fashion with 7/0 interrupted polypropylene suture. The ureteric anastomosis was done to the recipient bladder to form a neoureterocystostomy in the standard Lich-Gregoir fashion over a 5 Fr ureteric stent [7] . All transplants received standardized immunosuppression comprising of basiliximab induction and prednisolone, tacrolimus and mycophenolate triple therapy posttransplant.
The transplant recipients were followed up by the surgical and nephrological teams at designated intervals. All recipients had routine duplex imaging of the graft within the first week of transplant and whenever delayed function was encountered. Repeat duplex imaging was done thereafter based on clinical findings and requirement.
All grafts were followed up and compared for possible graft dysfunction, ar-Open Journal of Organ Transplant Surgery terial insufficiency and major urological complications. Delayed Graft Function (DGF) was defined as poor initial function after transplantation that required dialysis within the first week of the transplant. For the purposes of this study, any graft that demonstrated delayed function with failure to normalize serum creatinine levels within 72 hours of the transplant but not requiring haemodialysis were considered as slow graft function (SGF).
Results
A total of 312 live donor and 71 deceased donor transplants were carried out in our unit during the period of study. All 312 live donor recipients were recruited to the study, of whom 264 (85%) had SRA and 48 (15%) had MRA. The baseline characteristics of the study population is summarized in Table 1 . Among those with MRA, 41 had two, 5 had three and 2 had four arteries. Group 1 comprised of the 264 recipients of grafts with SRA. Group 2 had 39 patients and Group 3 had 9 patients. The mean overall ischaemia times, incidence of DGF or SGF, major urological complications, vascular complications, and 1-year graft survival are summarized in Table 2 . The ischaemia time in group 3 was less than in group 2, as the main artery was anastomosed first and graft reperfused while controlling the accessory artery with bull dog clamps. The accessory artery was then anastomosed while the rest of the kidney maintained perfusion. The ischaemia time in group 3 was less than in group 2, as the main artery was anastomosed first and graft reperfused prior to reconstructing the accessory artery. The mean follow-up was 16 (±4. 8) months. DGF requiring haemodialysis within the first week was encountered only in one patient in the entire study group, and belonged to group 2. This patient's DGF was a result of severe biopsy proven humoral rejection that required prolonged plasma exchange, intravenous immunoglobulin and rituximab therapy, thereby independent of the arterial anatomy. All patients with delayed function recovered graft function without the need for haemodialysis.
There were no instances of arterial insufficiency in the short term. There were two cases of transplant renal artery stenosis (TRAS) with resultant hypertension and graft dysfunction during continued follow up (9 & 13 months), one each in group 1 and 2. Both patients were successfully managed by percutaneous renal artery angioplasty.
There were 2 cases of ureteric stenosis, both in group 1, presenting at 13 and 17 weeks post-transplant. Both patients had normal arterial graft perfusion on duplex imaging and the ureteric stenosis was successfully managed with a period of ureteric stenting. Surgical intervention was not required in these two patients.
The patient in Group 2 with severe humoral rejection, discussed above, had complete ureteric dehiscence at approximately 8 weeks post-transplant with normal arterial graft perfusion. This was deemed unrelated to arterial inflow and a result of severe rejection and sustained heavy immunosuppression. The patency of both arteries in the graft was confirmed by pre-operative duplex as well as on-table assessment during ureteric re-implantation. The graft function was restored following treatment and the ureteric re-implantation was done.
Discussion
Although standard renal anatomy comprises of a single artery to each kidney arising from the aorta, the occurrence of MRA is a common anatomical variant.
In one study by Pollak and colleagues (1986) that looked at 400 cadaveric donors, 28% had MRA, with 23% demonstrating double, 4% triple and 1% quadruple arteries [8] . In a smaller study by Munnusamy and colleagues (2016) looking at live donors in India, 38% had MRA on pre-operative angiography; 13% on the right side, 13% on the left and 12% bilaterally [9] . This is comparable to other reports of MRA present unilaterally in 25% and bilaterally in 10% of the population.
Unlike renal veins which have multiple intrarenal anastomoses, allowing them to be ligated more freely, renal arteries are end arteries [10] . Ligation or injury to these arteries can render the supplied area ischemic, resulting in infarction.
Therefore, reconstruction of all donor renal arteries other than small capsular branches is mandatory to obtain maximal graft outcome. The vascular anasto- The arterial anastomosis in the recipient may be done to the common or EIA in an end-to-side fashion or to the internal iliac artery in an end-to-end fashion [13] . In our series, we practiced anastomosis to the recipient EIA as the standard practice in our unit. In cases of accessory donor arteries, the accessory artery can be reconstructed to the side of the main donor artery (Figure 1 In the case of deceased donors with MRA, all arteries may be removed along with a cuff of aorta (Carrel's patch), allowing for a single anastomosis in the recipient ( Figure 2 ) [16] . While this renders the anastomosis technically easier, the resulting long arterial pedicle may predispose to kinking of the artery post-transplant [17] . In LDRT, inadequate length of donor vessels or other anastomotic difficulties can be circumvented by using recipient vessels such as the IEA, gonadal vein or great saphenous vein to reconstruct the relevant vessels. In the absence of suitable native vessels Polytetrafluoroethylene (PTFE) grafts have also been used successfully in reconstruction of graft vessels [18] .
Both back-table reconstruction of the arteries and the creation of multiple in-situ arterial anastomoses prolong surgical ischemic times. However, extracorporeal reconstruction while in the cold preservation solution minimizes the warm ischaemia time while allowing for better visualization and easier suturing [19] . Alternatively, the main renal artery can be anastomosed to the recipient allowing earlier reperfusion of the graft while the accessory artery is kept under a soft clamp. This technique was used in our patients from group 3. This again will minimize the ischaemic time to the major portion of the graft, allowing for subsequent accessory artery anastomosis while the rest of the graft is being perfused.
Small capsular arteries which are less than 3 mm in diameter or are supplying <10% of the graft kidney can be ligated safely with no clinically significant impact on graft function [16] . However, arteries supplying the lower pole of the kidney must be preserved and reconstructed to avoid compromising blood flow grafts with MRA had no incidence of thrombosis [21] . Additional morbidities documented as being associated with MRA grafts include prolonged ischaemic time resulting in higher incidence of acute tubular necrosis, DGF and increased risk of rejection. MRA that require reconstruction have been thought to result in an increased incidence of TRAS with subsequent hypertension and possible reduced graft survival. For these reasons MRA was considered a relative contra-indication to kidney donation in the past [22] . The majority of these reservations were based on historical accounts of complications seen in deceased donor transplants. Better understanding of back-table arterial reconstruction, organ preservation with specialized preservation fluids and especially LDRT with minimal cold ischaemia times, have resulted in comparable results between grafts with SRA and MRA.
A systematic review and meta-analysis by Zorgdrager et al. (2016) comparing outcomes of recipients receiving MRA grafts or grafts with SRA showed higher rates of complications and DGF, as well as lower 1-year graft survival among patients with grafts with MRA [4] . However, this study looked at studies that included primarily deceased donor transplants and their outcomes. Rates of major urological complications in the MRA and SRA groups were 5.5% and 5% respectively. Vascular complications (arterial or venous thrombosis, TRAS, bleeding, hematoma, renal artery pseudo-aneurysm etc.) in the two groups were 10.8 and 8.1% respectively. Though statistically significant the pooled 1-year graft survival differed only mildly, being 93.2% in the MRA group and 94.5% in the SRA group. The long-term outcomes of 5-year graft survival and 1-and 5-year patient survival were similar in both groups. In our study of LDRT, we did not find any significant difference in outcomes between patients receiving grafts with SRA or MRA.
Other studies have not shown a difference in rates of acute tubular necrosis, biopsy proven acute rejection or overall graft survival in patients receiving grafts with SRA and MRA [21] . A study of 393 recipients by Makiyama et al. (2003) of grafts with MRA compared those who underwent reconstruction with those who did not [19] . As expected, total ischaemic times were longer in the reconstructed group. However, there was no difference in warm ischaemic times, early and late serum creatinine levels or acute rejection rates in the two groups. Post-transplant [21] . In our cohort, TRAS within the first year of follow up was encountered in one patient each in group 1 (SRA) and group 2 (MRA with a reconstructed ostium), which failed to reach statistical significance.
There are concerns about risks related to laparoscopic donor nephrectomy of grafts with MRA. In general, laparoscopic donor nephrectomy is preferred over open surgery as it is a less invasive procedure, avoids a large surgical scar, reduces post-operative pain and length of hospital stay [19] . There appear to be no differences between the donors with MRA and SRA undergoing laparoscopic nephrectomy in terms of serum creatinine and 1 year graft survival. A Korean study by Genc and colleagues (2011) comparing outcomes after laparoscopic donor nephrectomy for donor kidneys with one, two and three or more arteries found no difference in outcomes in terms of warm ischemia time and graft function [23] . In our cohort, laparoscopic nephrectomy was limited to 34 patients, all of whom had SRA. Limited expertise and facilities for laparoscopic donor nephrectomy in the public-sector health care system have limited its routine use in LDRT. However, with newer generation transplant surgeons with increased experience in laparoscopic live donor organ harvesting and expertise gained with the natural learning curve, we could look forward to laparoscopic nephrectomy extending in to all donor operations regardless of renal artery anatomy.
Conclusion
Recipients of grafts with MRA appear to have similar long-term outcomes compared to those of SRA. Although an increased incidence of perioperative vascular and urological complications has been observed in the past, this is largely limited to studies that looked at deceased donor grafts with numerous confounding variables such as increased cold ischaemia times and preservation damage.
Nevertheless, the use of an aortic patch often circumvents any technical difficulty associated with deceased donor grafts having multiple arteries. In contrast, live donors having multiple arteries require careful planning and reconstruction.
In the setting of a rising demand for renal allografts, donor grafts with MRA may be accepted safely with meticulous surgical reconstruction and close surveillance post-transplant. The observed short and medium-term graft outcomes show no significant difference to single artery grafts.
